ALLR · NASDAQ
Allarity Therapeutics (ALLR) Stock Price & Fundamentals
Allarity Therapeutics (ALLR) closed at $708.91 on Oct 9, 2026, down 0.27% from the previous close of $710.82.
Share price, past year
1Y +34.87%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $708.91 |
| Sep 30, 2026 | $698.25 |
| Aug 31, 2026 | $652.97 |
| Jul 31, 2026 | $641.83 |
| Jun 30, 2026 | $627.60 |
| May 29, 2026 | $624.37 |
| Apr 30, 2026 | $606.51 |
| Mar 31, 2026 | $612.89 |
| Feb 27, 2026 | $585.02 |
| Jan 30, 2026 | $587.22 |
| Dec 31, 2025 | $570.07 |
| Nov 28, 2025 | $573.83 |
| Oct 31, 2025 | $537.74 |
Key statistics
- Market cap
- $11.28B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$12.33M
- Shares outstanding
- 15.9M
- Dividend yield
- —
- 52-week range
- $515.42 – $710.82
Allarity Therapeutics's market cap is $11.28B, based on a share price of $708.91 and 15.9M shares outstanding as of Jun 30, 2026.
Financials
Allarity Therapeutics reported revenue of $320.00K for fiscal 2025.
Allarity Therapeutics reported a net loss of $11.23M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $320.00K | — | −$11.23M | −3,509.7% | — | −$14.83M |
| FY2024ended Dec 31, 2024 | $0.00 | — | −$24.52M | — | — | −$17.65M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $0.00 | −$3.41M | — |
| Q1 FY2026ended Mar 31, 2026 | $25.00K | −$2.75M | — |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$2.32M | — |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$2.73M | — |
Company profile
- Name
- Allarity Therapeutics, Inc.
- Ticker
- ALLR
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 24 School St., 2nd Floor, Boston, MA 02108
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001860657
Recent SEC filings
- Oct 1, 2026
- Sep 29, 2026
- Sep 16, 2026
- Sep 14, 2026
- Aug 14, 2026
- Aug 14, 2026
- Jul 1, 2026
- Jun 22, 2026
Frequently asked questions
What is Allarity Therapeutics's stock price?
Allarity Therapeutics (ALLR) closed at $708.91 on Oct 9, 2026, down 0.27% from the previous close of $710.82.
What is Allarity Therapeutics's market cap?
Allarity Therapeutics's market cap is $11.28B, based on a share price of $708.91 and 15.9M shares outstanding as of Jun 30, 2026.
How much revenue does Allarity Therapeutics make?
Allarity Therapeutics reported revenue of $320.00K for fiscal 2025.
Does Allarity Therapeutics pay a dividend?
Allarity Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Allarity Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures